Skip to content

Home Map The News Technology Politics Business Sports Entertainment Science Health World

Global AI-Powered News Intelligence. Real-time headlines, mapped by continent and country, from news sources worldwide.

Powered by AI

Navigate

Home
Map The News
About
Sources & methodology
Sources & methodology
Search

Sections

Technology
Politics
Business
Sports
Entertainment
Science

More

Privacy
Contact
Sitemap
Robots

© 2026 newsGlobal. All rights reserved.

Headlines refresh every 10 minutes.

Home Map Search Topics About

Home / Business

Business

Bloomberg

BusinessBloomberg·Aug 17, 2026·1 min read

Argenx Soars on Latest Trial Success for Autoimmune Drug Vyvgart

Argenx SE’s shares jumped after the European biotech reported the latest large, successful trial for its blockbuster drug Vyvgart.

View original source — Bloomberg ↗

ShareShare on X Share on Facebook

Related stories

China’s retail sales, factory activity lagged in July

BusinessAug 17, 2026 · 1 min

China’s retail sales, factory activity lagged in July

My son does not work, yet he pays $500 for ACA health insurance. How is that fair?

BusinessAug 17, 2026 · 1 min

My son does not work, yet he pays $500 for ACA health insurance. How is that fair?

BusinessAug 17, 2026 · 1 min

China main investor in Tatarstan — region head

Rakuten, German startup Helsing test military drones for Japan

BusinessAug 17, 2026 · 1 min

Rakuten, German startup Helsing test military drones for Japan